📊 BENFW Key Takeaways
Is Beneficient (BENFW) a Good Investment?
Beneficient is in severe financial distress with negative stockholders' equity of -$128.6M, indicating liabilities exceed assets by this amount. The company is burning cash at an alarming rate with -$34.8M free cash flow and minimal revenue of $3.3M against massive operating losses of -$106.6M. Without immediate strategic restructuring or significant capital infusion, the company faces existential solvency risk.
Beneficient’s fundamentals are extremely weak: revenue is minimal relative to losses, operating and net margins are deeply negative, and the business is consuming cash rather than generating it. While net income improved year over year, that improvement does not offset the core concerns of negative operating performance, negative free cash flow, weak liquidity, and negative stockholders’ equity.
Why Buy Beneficient Stock? BENFW Key Strengths
- Minimal capital expenditure requirements ($96K) suggests asset-light business model
- Some cash reserves remaining ($7.9M) provides short-term operational runway
- Recent dramatic net income improvement (YoY change suggests loss reduction from prior period)
- Net loss showed a large year-over-year improvement
- The company is generating some revenue rather than being entirely pre-revenue
- Capital expenditure needs appear low, which may limit incremental fixed-asset cash demands
BENFW Stock Risks: Beneficient Investment Risks
- Negative stockholders' equity of -$128.6M indicates balance sheet insolvency
- Operating cash flow of -$34.7M demonstrates inability to fund operations internally
- Revenue of only $3.3M cannot support $106.6M operating losses; business model is fundamentally broken
- Liabilities exceed assets by $38M with no viable path to profitability visible
- Zero insider buying activity suggests management lacks confidence in recovery
- Negative stockholders’ equity indicates severe balance-sheet stress
- Operating losses are extremely large relative to revenue, suggesting an unsustainable business model at current scale
- Low cash balance combined with negative operating and free cash flow raises funding and going-concern risk
Key Metrics to Watch
- Monthly operating cash flow trend - critical to survival timeline
- Cash balance depletion rate relative to burn rate
- Revenue growth acceleration - need exponential growth to offset losses
- Operating expense reduction progress and restructuring initiatives
- Debt covenant compliance status and refinancing ability
- Operating cash burn relative to cash on hand
- Revenue growth and operating margin improvement
Beneficient (BENFW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BENFW Profit Margin, ROE & Profitability Analysis
BENFW vs Finance Sector: How Beneficient Compares
How Beneficient compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Beneficient Stock Overvalued? BENFW Valuation Analysis 2026
Based on fundamental analysis, Beneficient has mixed fundamental signals relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Beneficient Balance Sheet: BENFW Debt, Cash & Liquidity
BENFW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Beneficient's revenue has declined by 106% over the 5-year period, indicating business contraction. The most recent EPS of $-1.27 indicates the company is currently unprofitable.
BENFW Revenue Growth, EPS Growth & YoY Performance
BENFW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $3.3M | -$8.6M | N/A |
| Q2 2026 | -$15.4M | N/A | N/A |
| Q1 2026 | -$12.6M | N/A | N/A |
| Q3 2025 | -$55.7M | N/A | N/A |
| Q2 2025 | -$45.5M | N/A | N/A |
| Q1 2025 | -$2.7M | N/A | N/A |
| Q3 2024 | -$86.4M | N/A | N/A |
| Q2 2024 | -$75.0M | N/A | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Beneficient Dividends, Buybacks & Capital Allocation
BENFW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Beneficient (CIK: 0001775734)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BENFW
What is the AI rating for BENFW?
Beneficient (BENFW) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 95% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BENFW's key strengths?
Claude: Minimal capital expenditure requirements ($96K) suggests asset-light business model. Some cash reserves remaining ($7.9M) provides short-term operational runway. ChatGPT: Net loss showed a large year-over-year improvement. The company is generating some revenue rather than being entirely pre-revenue.
What are the risks of investing in BENFW?
Claude: Negative stockholders' equity of -$128.6M indicates balance sheet insolvency. Operating cash flow of -$34.7M demonstrates inability to fund operations internally. ChatGPT: Negative stockholders’ equity indicates severe balance-sheet stress. Operating losses are extremely large relative to revenue, suggesting an unsustainable business model at current scale.
What is BENFW's revenue and growth?
Beneficient reported revenue of $3.3M.
Does BENFW pay dividends?
Beneficient does not currently pay dividends.
Where can I find BENFW SEC filings?
Official SEC filings for Beneficient (CIK: 0001775734) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BENFW's EPS?
Beneficient has a diluted EPS of $-1.94.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BENFW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Beneficient has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BENFW stock overvalued or undervalued?
Valuation metrics for BENFW: ROE of N/A (sector avg: 12%), net margin of -1,485.7% (sector avg: 25%). Compare these metrics with sector averages to assess valuation.
Should I buy BENFW stock in 2026?
Our dual AI analysis gives Beneficient a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BENFW's free cash flow?
Beneficient's operating cash flow is $-34.7M, with capital expenditures of $96.0K. FCF margin is -1,060.7%.
How does BENFW compare to other Finance stocks?
Vs Finance sector averages: Net margin -1,485.7% (avg: 25%), ROE N/A (avg: 12%), current ratio N/A (avg: 1.2).